GL Pharm Tech Corporation
18
1
1
15
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
0.0%
0 terminated/withdrawn out of 18 trials
100.0%
+13.5% vs industry average
11%
2 trials in Phase 3/4
0%
0 of 15 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (18)
Efficacy and Safety of AJU-S56 in Dry Eye Syndrome Patients
Role: collaborator
Efficacy and Safety of AJU-S56 5% in Dry Eye Syndrome Patients
Role: collaborator
Phase 2 Clinical Trial to Evaluate the Efficacy and Safety of GLH8NDE in Patients With Dry Eye Disease
Role: lead
A Clinical Trial to Evaluate the Safety, Tolerability and Pharmacokinetic Characteristics of GLH8NDE After Single and Mutiple Ocular Administrations in Healthy Korean and Caucasian Volunteers
Role: lead
Pharmacokinetic Characteristics of GLH1SM Extended Release Tablets in Healthy Volunteers(Fed)
Role: lead
The Pharmacokinetics of GLA5PR Tablet According to the Renal Function
Role: lead
Pharmacokinetic Characteristics of GLH1SM Extended Release Tablets in Healthy Volunteers
Role: lead
A PK Study GL2702 GLARS-NF1 and Omix Ocas® in Healthy Male Volunteers
Role: lead
Bioequivalence Study of Two Formulations of Pregabalin CR(Controlled-release) Table 300 mg
Role: lead
Bioequivalence Study of Two Formulations of Pregabalin CR (Controlled-release) Table 150 mg
Role: lead
Study to Investigate the Efficacy and Safety of GL2702 GLARS-NF1tablet and Harnal-D - Tablet in BPH Patients With LUTS
Role: lead
A Clinical Trial to Compare The Pharmacokinetics of A Pregabalin GLARS-NF1 Tablet 150mg With Immediate Release Formulation and to Assess The Effect of High Fat Diet in Healthy Male Subjects
Role: lead
A Randomized, Open-label, Single Dose, Parallel Study to Evaluate the Pharmacokinetics Dose Proportionality of GLA5PR GLARS-NF1 Tablet in Healthy Male Volunteers
Role: lead
PK Study of Pregabalin GLARS Tablet 150mg and IR Formulation After Multiple Dosing Under Fed Condition in Healthy Male Subjects
Role: lead
A Randomized, Open-label, Multiple-dose, Two-sequence, Two-period Crossover Study to Investigate The Pharmacokinetics Between a GL2907 and Oxycontin CR Tab. 10mg in Healthy Male Volunteers
Role: lead
PK Comparison of GL2701 With Finasteride and Tamsulosin in Combination
Role: collaborator
A Open-label, Single-dose Study to Investigate The Pharmacokinetics Between a GL2907 XL and Oxycontin CR Tab. 10mg in Healthy Male Volunteers
Role: lead
A Clinical Trial to Compare The Pharmacokinetics of A Pregabalin GLARS Tablet 150mg With Immediate Release Formulation and to Assess The Effect of High Fat Diet in Healthy Male Subjects
Role: lead
All 18 trials loaded